Investment in Securities (Tables)

6 Months Ended

Jun. 30, 2025

Investment in Securities [Abstract]

Schedule of Changes in Investments

The following table summarizes the changes in investments for the six months ended June 30, 2025 and year ended December 31, 2024:

	Public Company Investment			Private Company Investment			Convertible Debenture		Total
Balance, December 31, 2023	$	-			-			-		-
Purchases		-			139,084			-		139,084
Balance, December 31, 2024	$	-			139,084			-		139,084
Purchases	$	870,100			-			125,000		995,100
Transfer		139,084			(139,084	)		-		-
Acquired in the sale of Skincare business		728,550			-			-		728,550
Proceeds on sale		(1,109,921	)		-			-		(1,109,921	)
Interest		-			-			4,620		4,620
Realized loss		(371,494	)		-			-		(371,494	)
Unrealized loss		56,305			-			182,594		238,899
Balance, June 30, 2025	$	312,624			-			312,214		624,838

Schedule of Financial Instruments Measured at Fair Value on a Recurring Basis

The following table presents the Company’s financial instruments measured at fair value on a recurring basis as of June 30, 2025, in accordance with the fair value hierarchy of ASC 820: 

Fair Value Measurement Using:	Level 1		Level 2		Level 3		Total
Equity securities	$	312,624		–		–		312,624
Convertible debenture		-		312,214		–		312,214
Total	$	312,624		312,214		–		624,838